Apo-Meprobamate

insomnia, menopausal and premenstrual syndromes - all these conditions are accompanied by increased anxiety and stress, which can negatively affect the quality of life of patients. In such cases, the drug Apo-Meprobamate, which belongs to the group of tranquilizers - carbamic esters of substituted propanediol, can help.

Apo-Meprobamate is manufactured by the Canadian company Apotex Inc. and contains the active ingredient meprobamate. Dosage form: 400 mg tablets. The drug is indicated in the treatment of neuroses, anxiety disorders, insomnia, menopause and premenstrual syndromes.

Apo-Meprobamate should not be used in case of hypersensitivity to meprobamate or other carbamate derivatives, alcoholism, drug dependence, epilepsy, myasthenia gravis, liver and/or renal failure, acute intermittent porphyria, pregnancy (especially in the first trimester), breastfeeding and in children under 6 years.

When using Apo-Meprobamate, side effects may occur, including weakness, drowsiness, dizziness, headache, insomnia, impaired memory and attention, hyporeflexia, nervousness or anxiety, incoordination, blurred vision, euphoria, paradoxical reaction (unusual arousal), false feeling of well-being. Palpitations, tachycardia, arrhythmia, decreased blood pressure, leukopenia, thrombocytopenia, decreased salivation, nausea, vomiting, diarrhea, dyspeptic symptoms, skin rash, itching, urticaria and other allergic reactions may also be observed. The development of addiction, drug dependence and withdrawal syndrome is possible.

When using Apo-Meprobamate, it is necessary to take into account the possibility of interaction with other drugs, including alcohol, analgesics, antipsychotics, anesthetics, hypnotics and antihypertensive drugs, peripheral muscle relaxants. Overdose may result in acute toxicity, symptoms of which include severe confusion, severe dizziness, shortness of breath or difficulty breathing, slow heartbeat and significant weakness. Chronic toxicity may cause prolonged dizziness and slurred speech.

Elderly patients should be prescribed lower doses of Apo-Meprobamate, as they may have reduced kidney and liver function, which may lead to increased concentrations of the drug in the body.

Before starting to use Apo-Meprobamate, you must consult your doctor and strictly follow the recommendations on dosage and duration of treatment. You should not self-medicate or exceed the recommended dose, as this may lead to negative health consequences.

In addition, it is important to remember that Apo-Meprobamate may increase the risk of developing suicidal thoughts and behavior, especially in patients with depression and other mental disorders. If such symptoms appear, you should immediately seek medical help.

Overall, Apo-Meprobamate is an effective drug for the treatment of anxiety disorders, insomnia and other conditions associated with stress and anxiety. However, its use must be strictly controlled and under the supervision of a physician.